$JNP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in JUNIPER PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in JUNIPER PHARMACEUTICALS INC. Get notifications about new insider transactions in JUNIPER PHARMACEUTICALS INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 05 2011 | JNP | JUNIPER PHARMACEUT ... | BLECHSCHMIDT EDWARD A | Director | Grant | A | 0.01 | 8,720 | 87 | 92,470 | 83.8 K to 92.5 K (+10.41 %) |
May 05 2011 | JNP | JUNIPER PHARMACEUT ... | BLECHSCHMIDT EDWARD A | Director | Payment of Exercise | F | 3.44 | 14,018 | 48,222 | 83,750 | 97.8 K to 83.8 K (-14.34 %) |
Feb 08 2011 | JNP | JUNIPER PHARMACEUT ... | Gyenes Lawrence A | SVP, CFO | Option Exercise | A | 2.59 | 135,000 | 349,650 | 135,000 | |
Feb 08 2011 | JNP | JUNIPER PHARMACEUT ... | MCGRANE MICHAEL | Senior VP & General ... | Option Exercise | A | 2.59 | 135,000 | 349,650 | 135,000 | |
Feb 08 2011 | JNP | JUNIPER PHARMACEUT ... | CONDELLA FRANK JR | President and CEO | Option Exercise | A | 2.59 | 315,000 | 815,850 | 315,000 | |
Sep 16 2010 | JNP | JUNIPER PHARMACEUT ... | CONDELLA FRANK JR | President and CEO | Option Exercise | A | 1.07 | 350,000 | 374,500 | 350,000 | |
Sep 16 2010 | JNP | JUNIPER PHARMACEUT ... | MCGRANE MICHAEL | Senior VP & General ... | Option Exercise | A | 1.07 | 150,000 | 160,500 | 150,000 | |
Sep 16 2010 | JNP | JUNIPER PHARMACEUT ... | Gyenes Lawrence A | SVP, CFO | Option Exercise | A | 1.07 | 150,000 | 160,500 | 150,000 | |
Sep 16 2010 | JNP | JUNIPER PHARMACEUT ... | BLECHSCHMIDT EDWARD A | Director | Grant | A | 0.01 | 28,037 | 280 | 97,768 | 69.7 K to 97.8 K (+40.21 %) |
Sep 16 2010 | JNP | JUNIPER PHARMACEUT ... | KASNET STEPHEN G | Director | Grant | A | 0.01 | 28,037 | 280 | 153,018 | 125 K to 153 K (+22.43 %) |
Jul 07 2010 | JNP | JUNIPER PHARMACEUT ... | CAMPBELL ANTHONY R | Director | Option Exercise | J | 1.35 | 10,661 | 14,392 | 10,661 | |
Jul 07 2010 | JNP | JUNIPER PHARMACEUT ... | CAMPBELL ANTHONY R | Director | Option Exercise | J | 1.35 | 30,619 | 41,336 | 30,619 | |
Jul 07 2010 | JNP | JUNIPER PHARMACEUT ... | CAMPBELL ANTHONY R | Director | Option Exercise | J | 1.35 | 16,086 | 21,716 | 16,086 | |
Jul 07 2010 | JNP | JUNIPER PHARMACEUT ... | CAMPBELL ANTHONY R | Director | Option Exercise | J | 1.35 | 763,566 | 1,030,814 | 763,566 | |
Jul 07 2010 | JNP | JUNIPER PHARMACEUT ... | CAMPBELL ANTHONY R | Director | Option Exercise | J | 1.35 | 121,705 | 164,302 | 121,705 | |
Jul 07 2010 | JNP | JUNIPER PHARMACEUT ... | CAMPBELL ANTHONY R | Director | Option Exercise | J | 1.35 | 26,355 | 35,579 | 26,355 | |
Jul 07 2010 | JNP | JUNIPER PHARMACEUT ... | CAMPBELL ANTHONY R | Director | Option Exercise | J | 5.25 | 10,476 | 54,999 | 0 | |
Jul 07 2010 | JNP | JUNIPER PHARMACEUT ... | CAMPBELL ANTHONY R | Director | Option Exercise | J | 5.25 | 30,095 | 157,999 | 0 | |
Jul 07 2010 | JNP | JUNIPER PHARMACEUT ... | CAMPBELL ANTHONY R | Director | Option Exercise | J | 5.25 | 15,810 | 83,003 | 0 | |
Jul 07 2010 | JNP | JUNIPER PHARMACEUT ... | CAMPBELL ANTHONY R | Director | Option Exercise | J | 5.25 | 750,476 | 3,939,999 | 0 | |
Jul 07 2010 | JNP | JUNIPER PHARMACEUT ... | CAMPBELL ANTHONY R | Director | Option Exercise | J | 5.25 | 119,619 | 628,000 | 0 | |
Jul 07 2010 | JNP | JUNIPER PHARMACEUT ... | CAMPBELL ANTHONY R | Director | Option Exercise | J | 5.25 | 25,905 | 136,001 | 0 | |
Jul 07 2010 | JNP | JUNIPER PHARMACEUT ... | CAMPBELL ANTHONY R | Director | Buy | J | 0.00 | 10,362 | 0 | 10,362 | 0 to 10.4 K |
Jul 07 2010 | JNP | JUNIPER PHARMACEUT ... | CAMPBELL ANTHONY R | Director | Buy | J | 0.00 | 29,606 | 0 | 95,585 | 66 K to 95.6 K (+44.87 %) |
Jul 07 2010 | JNP | JUNIPER PHARMACEUT ... | CAMPBELL ANTHONY R | Director | Buy | J | 0.00 | 15,543 | 0 | 15,543 | 0 to 15.5 K |
Jul 07 2010 | JNP | JUNIPER PHARMACEUT ... | CAMPBELL ANTHONY R | Director | Buy | J | 0.00 | 729,047 | 0 | 1,704,642 | 975.6 K to 1.7 M (+74.73 %) |
Jul 07 2010 | JNP | JUNIPER PHARMACEUT ... | CAMPBELL ANTHONY R | Director | Buy | J | 0.00 | 116,203 | 0 | 692,303 | 576.1 K to 692.3 K (+20.17 %) |
Jul 07 2010 | JNP | JUNIPER PHARMACEUT ... | CAMPBELL ANTHONY R | Director | Buy | J | 0.00 | 25,165 | 0 | 1,488,488 | 1.5 M to 1.5 M (+1.72 %) |
Sep 16 2010 | JNP | JUNIPER PHARMACEUT ... | Andrews Valerie Lynne | Director | Grant | A | 0.01 | 28,037 | 280 | 57,326 | 29.3 K to 57.3 K (+95.73 %) |
Jul 06 2010 | JNP | JUNIPER PHARMACEUT ... | OSKOWITZ SELWYN P | Director | Payment of Exercise | F | 1.03 | 7,692 | 7,923 | 32,989 | 40.7 K to 33 K (-18.91 %) |
Jul 06 2010 | JNP | JUNIPER PHARMACEUT ... | Andrews Valerie Lynne | Director | Payment of Exercise | F | 1.03 | 7,692 | 7,923 | 29,289 | 37 K to 29.3 K (-20.80 %) |
May 25 2010 | JNP | JUNIPER PHARMACEUT ... | MCGRANE MICHAEL | Senior VP & General ... | Payment of Exercise | F | 1.14 | 688 | 784 | 89,761 | 90.4 K to 89.8 K (-0.76 %) |
Mar 16 2010 | JNP | JUNIPER PHARMACEUT ... | CONDELLA FRANK JR | Interim CEO | Buy | P | 1.12 | 100,000 | 112,150 | 162,764 | 62.8 K to 162.8 K (+159.33 %) |
Mar 12 2010 | JNP | JUNIPER PHARMACEUT ... | MILLS ROBERT S | President & COO | Payment of Exercise | F | 1.06 | 2,400 | 2,544 | 101,800 | 104.2 K to 101.8 K (-2.30 %) |
Mar 12 2010 | JNP | JUNIPER PHARMACEUT ... | MCGRANE MICHAEL | Senior VP & General ... | Payment of Exercise | F | 1.06 | 1,750 | 1,855 | 90,449 | 92.2 K to 90.4 K (-1.90 %) |
Mar 04 2010 | JNP | JUNIPER PHARMACEUT ... | MILLS ROBERT S | President & CEO | Payment of Exercise | F | 1.35 | 2,400 | 3,240 | 104,200 | 106.6 K to 104.2 K (-2.25 %) |
Mar 04 2010 | JNP | JUNIPER PHARMACEUT ... | MCGRANE MICHAEL | Senior VP & General ... | Payment of Exercise | F | 1.35 | 1,750 | 2,363 | 92,199 | 93.9 K to 92.2 K (-1.86 %) |
Mar 02 2010 | JNP | JUNIPER PHARMACEUT ... | MILLS ROBERT S | President & COO | Payment of Exercise | F | 1.30 | 2,000 | 2,600 | 106,600 | 108.6 K to 106.6 K (-1.84 %) |
Mar 02 2010 | JNP | JUNIPER PHARMACEUT ... | MCGRANE MICHAEL | Senior VP & General ... | Payment of Exercise | F | 1.30 | 1,600 | 2,080 | 93,949 | 95.5 K to 93.9 K (-1.67 %) |
Dec 14 2009 | JNP | JUNIPER PHARMACEUT ... | CONDELLA FRANK JR | Director | Option Exercise | A | 0.87 | 100,000 | 87,000 | 100,000 | |
Nov 13 2009 | JNP | JUNIPER PHARMACEUT ... | OSKOWITZ SELWYN P | Director | Buy | P | 0.99 | 700 | 693 | 40,681 | 40 K to 40.7 K (+1.75 %) |
Nov 13 2009 | JNP | JUNIPER PHARMACEUT ... | OSKOWITZ SELWYN P | Director | Buy | P | 0.85 | 1,000 | 848 | 39,981 | 39 K to 40 K (+2.57 %) |
Nov 12 2009 | JNP | JUNIPER PHARMACEUT ... | KASNET STEPHEN G | Director | Buy | P | 0.99 | 10,000 | 9,885 | 124,981 | 115 K to 125 K (+8.70 %) |
Nov 10 2009 | JNP | JUNIPER PHARMACEUT ... | KASNET STEPHEN G | Director | Buy | P | 0.85 | 40,000 | 34,104 | 114,981 | 75 K to 115 K (+53.35 %) |
Nov 10 2009 | JNP | JUNIPER PHARMACEUT ... | Gyenes Lawrence A | Senior Vice Prsiden ... | Buy | P | 0.87 | 50,000 | 43,285 | 50,000 | 0 to 50 K |
Oct 01 2009 | JNP | JUNIPER PHARMACEUT ... | CONDELLA FRANK JR | Director | Grant | A | 0.01 | 12,000 | 120 | 62,764 | 50.8 K to 62.8 K (+23.64 %) |
Oct 01 2009 | JNP | JUNIPER PHARMACEUT ... | CONDELLA FRANK JR | Director | Payment of Exercise | F | 1.29 | 14,400 | 18,576 | 50,764 | 65.2 K to 50.8 K (-22.10 %) |
Sep 02 2009 | JNP | JUNIPER PHARMACEUT ... | CONDELLA FRANK JR | Director | Grant | A | 0.01 | 12,000 | 120 | 65,164 | 53.2 K to 65.2 K (+22.57 %) |
Aug 04 2009 | JNP | JUNIPER PHARMACEUT ... | CONDELLA FRANK JR | Director | Grant | A | 0.01 | 12,000 | 120 | 53,164 | 41.2 K to 53.2 K (+29.15 %) |
Jul 22 2009 | JNP | JUNIPER PHARMACEUT ... | CONDELLA FRANK JR | Director | Grant | A | 0.01 | 12,000 | 120 | 41,164 | 29.2 K to 41.2 K (+41.15 %) |
May 26 2009 | JNP | JUNIPER PHARMACEUT ... | OSKOWITZ SELWYN P | Director | Grant | A | 0.01 | 19,230 | 192 | 38,981 | 19.8 K to 39 K (+97.36 %) |
May 26 2009 | JNP | JUNIPER PHARMACEUT ... | OSKOWITZ SELWYN P | Director | Payment of Exercise | F | 1.30 | 3,448 | 4,482 | 19,751 | 23.2 K to 19.8 K (-14.86 %) |
May 26 2009 | JNP | JUNIPER PHARMACEUT ... | ODONNELL DENIS M | Director | Grant | A | 1.30 | 3,448 | 4,482 | 17,751 | 21.2 K to 17.8 K (-16.26 %) |
May 26 2009 | JNP | JUNIPER PHARMACEUT ... | KASNET STEPHEN G | Director | Grant | A | 0.01 | 19,230 | 192 | 74,981 | 55.8 K to 75 K (+34.49 %) |
May 26 2009 | JNP | JUNIPER PHARMACEUT ... | KASNET STEPHEN G | Director | Payment of Exercise | F | 1.30 | 3,448 | 4,482 | 55,751 | 59.2 K to 55.8 K (-5.82 %) |
May 26 2009 | JNP | JUNIPER PHARMACEUT ... | Crofton James Scott | Director | Grant | A | 0.01 | 19,230 | 192 | 36,981 | 17.8 K to 37 K (+108.33 %) |
May 26 2009 | JNP | JUNIPER PHARMACEUT ... | Crofton James Scott | Director | Payment of Exercise | F | 1.30 | 3,448 | 4,482 | 17,751 | 21.2 K to 17.8 K (-16.26 %) |
May 26 2009 | JNP | JUNIPER PHARMACEUT ... | BLECHSCHMIDT EDWARD A | Director | Grant | A | 0.01 | 19,230 | 192 | 69,731 | 50.5 K to 69.7 K (+38.08 %) |
May 26 2009 | JNP | JUNIPER PHARMACEUT ... | BLECHSCHMIDT EDWARD A | Director | Payment of Exercise | F | 1.30 | 3,448 | 4,482 | 50,501 | 53.9 K to 50.5 K (-6.39 %) |
May 26 2009 | JNP | JUNIPER PHARMACEUT ... | CONDELLA FRANK JR | Director | Grant | A | 0.01 | 19,230 | 192 | 29,164 | 9.9 K to 29.2 K (+193.58 %) |
May 26 2009 | JNP | JUNIPER PHARMACEUT ... | CONDELLA FRANK JR | Director | Payment of Exercise | F | 1.30 | 6,622 | 8,609 | 9,934 | 16.6 K to 9.9 K (-40.00 %) |
May 26 2009 | JNP | JUNIPER PHARMACEUT ... | Andrews Valerie Lynne | Director | Grant | A | 0.01 | 19,230 | 192 | 36,981 | 17.8 K to 37 K (+108.33 %) |
May 26 2009 | JNP | JUNIPER PHARMACEUT ... | Andrews Valerie Lynne | Director | Payment of Exercise | F | 1.30 | 3,448 | 4,482 | 17,751 | 21.2 K to 17.8 K (-16.26 %) |
May 26 2009 | JNP | JUNIPER PHARMACEUT ... | CAMPBELL ANTHONY R | Director | Grant | A | 0.00 | 19,230 | 0 | 122,265 | 103 K to 122.3 K (+18.66 %) |
May 26 2009 | JNP | JUNIPER PHARMACEUT ... | CAMPBELL ANTHONY R | Director | Payment of Exercise | F | 1.30 | 8,333 | 10,833 | 103,035 | 94.7 K to 103 K (+8.80 %) |
May 18 2009 | JNP | JUNIPER PHARMACEUT ... | MCGRANE MICHAEL | Senior VP & General ... | Payment of Exercise | F | 1.50 | 688 | 1,032 | 95,549 | 96.2 K to 95.5 K (-0.71 %) |
May 18 2009 | JNP | JUNIPER PHARMACEUT ... | MILLS ROBERT S | President & CEO | Payment of Exercise | F | 1.50 | 1,000 | 1,500 | 108,600 | 109.6 K to 108.6 K (-0.91 %) |
May 18 2009 | JNP | JUNIPER PHARMACEUT ... | MCGRANE MICHAEL | Senior VP & General ... | Payment of Exercise | F | 1.50 | 688 | 1,032 | 95,549 | 96.2 K to 95.5 K (-0.71 %) |
Mar 27 2009 | JNP | JUNIPER PHARMACEUT ... | CAMPBELL ANTHONY R | Director | Option Exercise | S | 1.49 | 175 | 261 | 0 | |
Mar 27 2009 | JNP | JUNIPER PHARMACEUT ... | CAMPBELL ANTHONY R | Director | Buy | P | 0.00 | 117,449 | 0 | 126,574 | 9.1 K to 126.6 K (+1,287.11 %) |
Mar 12 2009 | JNP | JUNIPER PHARMACEUT ... | Meer James | Senior VP & CFO | Option Exercise | A | 1.33 | 108,000 | 143,640 | 40,450 | |
Mar 12 2009 | JNP | JUNIPER PHARMACEUT ... | Meer James | Senior VP & CFO | Grant | A | 0.01 | 17,500 | 175 | 40,450 | 23 K to 40.5 K (+76.25 %) |
Mar 12 2009 | JNP | JUNIPER PHARMACEUT ... | MILLS ROBERT S | President & CEO | Option Exercise | A | 1.33 | 140,000 | 186,200 | 109,600 | |
Mar 12 2009 | JNP | JUNIPER PHARMACEUT ... | MILLS ROBERT S | President & CEO | Grant | A | 0.01 | 24,000 | 240 | 109,600 | 85.6 K to 109.6 K (+28.04 %) |
Mar 12 2009 | JNP | JUNIPER PHARMACEUT ... | MCGRANE MICHAEL | Senior VP & General ... | Option Exercise | A | 1.33 | 108,000 | 143,640 | 96,237 | |
Mar 12 2009 | JNP | JUNIPER PHARMACEUT ... | MCGRANE MICHAEL | Senior VP & General ... | Grant | A | 0.01 | 17,500 | 175 | 96,237 | 78.7 K to 96.2 K (+22.23 %) |
Mar 04 2009 | JNP | JUNIPER PHARMACEUT ... | MILLS ROBERT S | President & CEO | Payment of Exercise | F | 1.53 | 2,400 | 3,672 | 85,600 | 88 K to 85.6 K (-2.73 %) |
Mar 04 2009 | JNP | JUNIPER PHARMACEUT ... | MILLS ROBERT S | President & CEO | Payment of Exercise | F | 1.37 | 2,000 | 2,740 | 88,000 | 90 K to 88 K (-2.22 %) |
Mar 04 2009 | JNP | JUNIPER PHARMACEUT ... | Meer James | Senior VP & CFO | Payment of Exercise | F | 1.53 | 1,750 | 2,678 | 22,950 | 24.7 K to 23 K (-7.09 %) |
Mar 04 2009 | JNP | JUNIPER PHARMACEUT ... | Meer James | Senior VP & CFO | Payment of Exercise | F | 1.37 | 1,400 | 1,918 | 24,700 | 26.1 K to 24.7 K (-5.36 %) |
Mar 04 2009 | JNP | JUNIPER PHARMACEUT ... | MCGRANE MICHAEL | Senior VP & General ... | Payment of Exercise | F | 1.53 | 1,750 | 2,678 | 78,737 | 80.5 K to 78.7 K (-2.17 %) |
Mar 04 2009 | JNP | JUNIPER PHARMACEUT ... | MCGRANE MICHAEL | Senior VP & General ... | Payment of Exercise | F | 1.37 | 1,600 | 2,192 | 80,487 | 82.1 K to 80.5 K (-1.95 %) |
Feb 19 2009 | JNP | JUNIPER PHARMACEUT ... | CAMPBELL ANTHONY R | Director | Option Exercise | J | 1.38 | 25,000 | 34,500 | 25,000 | |
Jul 29 2008 | JNP | JUNIPER PHARMACEUT ... | Meer James | Senior VP & CFO | Payment of Exercise | F | 4.26 | 4,000 | 17,040 | 26,100 | 30.1 K to 26.1 K (-13.29 %) |
May 15 2008 | JNP | JUNIPER PHARMACEUT ... | MCGRANE MICHAEL | Senior VP & General ... | Payment of Exercise | F | 3.00 | 688 | 2,064 | 82,087 | 82.8 K to 82.1 K (-0.83 %) |
May 15 2008 | JNP | JUNIPER PHARMACEUT ... | ODONNELL DENIS M | Director | Payment of Exercise | F | 3.00 | 1,000 | 3,000 | 21,199 | 22.2 K to 21.2 K (-4.50 %) |
May 15 2008 | JNP | JUNIPER PHARMACEUT ... | ODONNELL DENIS M | Director | Grant | A | 0.01 | 8,620 | 86 | 22,199 | 13.6 K to 22.2 K (+63.48 %) |
May 15 2008 | JNP | JUNIPER PHARMACEUT ... | ODONNELL DENIS M | Director | Payment of Exercise | F | 2.90 | 4,386 | 12,719 | 13,579 | 18 K to 13.6 K (-24.41 %) |
May 15 2008 | JNP | JUNIPER PHARMACEUT ... | MILLS ROBERT S | President & CEO | Payment of Exercise | F | 3.00 | 1,000 | 3,000 | 90,000 | 91 K to 90 K (-1.10 %) |
May 15 2008 | JNP | JUNIPER PHARMACEUT ... | Crofton James Scott | Director | Payment of Exercise | F | 3.00 | 1,000 | 3,000 | 21,199 | 22.2 K to 21.2 K (-4.50 %) |
May 15 2008 | JNP | JUNIPER PHARMACEUT ... | Crofton James Scott | Director | Grant | A | 0.01 | 8,620 | 86 | 22,199 | 13.6 K to 22.2 K (+63.48 %) |
May 15 2008 | JNP | JUNIPER PHARMACEUT ... | Crofton James Scott | Director | Payment of Exercise | F | 2.90 | 4,386 | 12,719 | 13,579 | 18 K to 13.6 K (-24.41 %) |
May 15 2008 | JNP | JUNIPER PHARMACEUT ... | KASNET STEPHEN G | Director | Payment of Exercise | F | 3.00 | 1,000 | 3,000 | 59,199 | 60.2 K to 59.2 K (-1.66 %) |
May 15 2008 | JNP | JUNIPER PHARMACEUT ... | KASNET STEPHEN G | Director | Grant | A | 0.01 | 8,620 | 86 | 60,199 | 51.6 K to 60.2 K (+16.71 %) |
May 15 2008 | JNP | JUNIPER PHARMACEUT ... | KASNET STEPHEN G | Director | Payment of Exercise | F | 2.90 | 4,386 | 12,719 | 51,579 | 56 K to 51.6 K (-7.84 %) |
May 15 2008 | JNP | JUNIPER PHARMACEUT ... | BLECHSCHMIDT EDWARD A | Director | Payment of Exercise | F | 3.00 | 1,000 | 3,000 | 53,949 | 54.9 K to 53.9 K (-1.82 %) |
May 15 2008 | JNP | JUNIPER PHARMACEUT ... | BLECHSCHMIDT EDWARD A | Director | Grant | A | 0.01 | 8,620 | 86 | 54,949 | 46.3 K to 54.9 K (+18.61 %) |
May 15 2008 | JNP | JUNIPER PHARMACEUT ... | BLECHSCHMIDT EDWARD A | Director | Payment of Exercise | F | 2.90 | 4,386 | 12,719 | 46,329 | 50.7 K to 46.3 K (-8.65 %) |
May 15 2008 | JNP | JUNIPER PHARMACEUT ... | OSKOWITZ SELWYN P | Director | Payment of Exercise | F | 3.00 | 1,000 | 3,000 | 23,199 | 24.2 K to 23.2 K (-4.13 %) |
May 15 2008 | JNP | JUNIPER PHARMACEUT ... | OSKOWITZ SELWYN P | Director | Grant | A | 0.01 | 8,620 | 86 | 24,199 | 15.6 K to 24.2 K (+55.33 %) |
May 15 2008 | JNP | JUNIPER PHARMACEUT ... | OSKOWITZ SELWYN P | Director | Payment of Exercise | F | 2.90 | 4,386 | 12,719 | 15,579 | 20 K to 15.6 K (-21.97 %) |
May 15 2008 | JNP | JUNIPER PHARMACEUT ... | Andrews Valerie Lynne | Director | Payment of Exercise | F | 3.00 | 1,000 | 3,000 | 21,199 | 22.2 K to 21.2 K (-4.50 %) |
May 15 2008 | JNP | JUNIPER PHARMACEUT ... | Andrews Valerie Lynne | Director | Grant | A | 0.01 | 8,620 | 86 | 22,199 | 13.6 K to 22.2 K (+63.48 %) |
May 15 2008 | JNP | JUNIPER PHARMACEUT ... | Andrews Valerie Lynne | Director | Payment of Exercise | F | 2.90 | 4,386 | 12,719 | 13,579 | 18 K to 13.6 K (-24.41 %) |
Mar 03 2008 | JNP | JUNIPER PHARMACEUT ... | Meer James | Senior VP & CFO | Option Exercise | A | 3.00 | 29,000 | 87,000 | 30,100 | |
Mar 03 2008 | JNP | JUNIPER PHARMACEUT ... | Meer James | Senior VP & CFO | Option Exercise | A | 2.40 | 91,000 | 218,400 | 30,100 | |
Mar 03 2008 | JNP | JUNIPER PHARMACEUT ... | Meer James | Senior VP & CFO | Grant | A | 0.01 | 17,500 | 175 | 30,100 | 12.6 K to 30.1 K (+138.89 %) |
Mar 03 2008 | JNP | JUNIPER PHARMACEUT ... | Meer James | Senior VP & CFO | Payment of Exercise | F | 2.42 | 1,400 | 3,388 | 12,600 | 14 K to 12.6 K (-10.00 %) |
Mar 03 2008 | JNP | JUNIPER PHARMACEUT ... | MCGRANE MICHAEL | Senior VP & General ... | Option Exercise | A | 3.00 | 16,000 | 48,000 | 82,775 | |
Mar 03 2008 | JNP | JUNIPER PHARMACEUT ... | MCGRANE MICHAEL | Senior VP & General ... | Option Exercise | A | 2.40 | 104,000 | 249,600 | 82,775 | |
Mar 03 2008 | JNP | JUNIPER PHARMACEUT ... | MCGRANE MICHAEL | Senior VP & General ... | Grant | A | 0.01 | 17,500 | 175 | 82,775 | 65.3 K to 82.8 K (+26.81 %) |
Mar 03 2008 | JNP | JUNIPER PHARMACEUT ... | MCGRANE MICHAEL | Senior VP & General ... | Payment of Exercise | F | 2.42 | 1,600 | 3,872 | 65,275 | 66.9 K to 65.3 K (-2.39 %) |
Mar 03 2008 | JNP | JUNIPER PHARMACEUT ... | MILLS ROBERT S | President & CEO | Option Exercise | A | 3.00 | 45,000 | 135,000 | 91,000 | |
Mar 03 2008 | JNP | JUNIPER PHARMACEUT ... | MILLS ROBERT S | President & CEO | Option Exercise | A | 2.40 | 130,000 | 312,000 | 91,000 | |
Mar 03 2008 | JNP | JUNIPER PHARMACEUT ... | MILLS ROBERT S | President & CEO | Grant | A | 0.01 | 24,000 | 240 | 91,000 | 67 K to 91 K (+35.82 %) |
Mar 03 2008 | JNP | JUNIPER PHARMACEUT ... | MILLS ROBERT S | President & CEO | Payment of Exercise | F | 2.42 | 2,000 | 4,840 | 67,000 | 69 K to 67 K (-2.90 %) |
Nov 16 2007 | JNP | JUNIPER PHARMACEUT ... | ODONNELL DENIS M | Director | Payment of Exercise | F | 2.32 | 1,000 | 2,315 | 17,965 | 19 K to 18 K (-5.27 %) |
Nov 16 2007 | JNP | JUNIPER PHARMACEUT ... | BLECHSCHMIDT EDWARD A | Director | Payment of Exercise | F | 2.32 | 1,000 | 2,315 | 50,715 | 51.7 K to 50.7 K (-1.93 %) |
Nov 16 2007 | JNP | JUNIPER PHARMACEUT ... | Crofton James Scott | Director | Payment of Exercise | F | 2.32 | 1,000 | 2,315 | 17,965 | 19 K to 18 K (-5.27 %) |
Nov 16 2007 | JNP | JUNIPER PHARMACEUT ... | OSKOWITZ SELWYN P | Director | Payment of Exercise | F | 2.32 | 1,000 | 2,315 | 19,965 | 21 K to 20 K (-4.77 %) |
Nov 16 2007 | JNP | JUNIPER PHARMACEUT ... | Andrews Valerie Lynne | Director | Payment of Exercise | F | 2.32 | 1,000 | 2,315 | 17,965 | 19 K to 18 K (-5.27 %) |
Nov 16 2007 | JNP | JUNIPER PHARMACEUT ... | KASNET STEPHEN G | Director | Payment of Exercise | F | 2.32 | 1,000 | 2,315 | 55,965 | 57 K to 56 K (-1.76 %) |
Nov 16 2007 | JNP | JUNIPER PHARMACEUT ... | ODONNELL DENIS M | Director | Payment of Exercise | F | 2.32 | 1,000 | 2,315 | 17,965 | 19 K to 18 K (-5.27 %) |
May 17 2007 | JNP | JUNIPER PHARMACEUT ... | OSKOWITZ SELWYN P | Director | Grant | A | 0.01 | 10,965 | 110 | 20,965 | 10 K to 21 K (+109.65 %) |
May 17 2007 | JNP | JUNIPER PHARMACEUT ... | OSKOWITZ SELWYN P | Director | Payment of Exercise | F | 2.21 | 1,000 | 2,210 | 10,000 | 11 K to 10 K (-9.09 %) |
May 17 2007 | JNP | JUNIPER PHARMACEUT ... | BLECHSCHMIDT EDWARD A | Director | Grant | A | 0.01 | 10,965 | 110 | 74,965 | 64 K to 75 K (+17.13 %) |
May 17 2007 | JNP | JUNIPER PHARMACEUT ... | BLECHSCHMIDT EDWARD A | Director | Payment of Exercise | F | 2.21 | 1,000 | 2,210 | 64,000 | 65 K to 64 K (-1.54 %) |
May 17 2007 | JNP | JUNIPER PHARMACEUT ... | ODONNELL DENIS M | Director | Grant | A | 0.01 | 10,965 | 110 | 18,965 | 8 K to 19 K (+137.06 %) |
May 17 2007 | JNP | JUNIPER PHARMACEUT ... | ODONNELL DENIS M | Director | Payment of Exercise | F | 2.21 | 1,000 | 2,210 | 8,000 | 9 K to 8 K (-11.11 %) |
May 17 2007 | JNP | JUNIPER PHARMACEUT ... | Crofton James Scott | Director | Grant | A | 0.01 | 10,965 | 110 | 18,965 | 8 K to 19 K (+137.06 %) |
May 17 2007 | JNP | JUNIPER PHARMACEUT ... | Crofton James Scott | Director | Payment of Exercise | F | 2.21 | 1,000 | 2,210 | 8,000 | 9 K to 8 K (-11.11 %) |
May 17 2007 | JNP | JUNIPER PHARMACEUT ... | Andrews Valerie Lynne | Director | Grant | A | 0.01 | 10,965 | 110 | 18,965 | 8 K to 19 K (+137.06 %) |
May 17 2007 | JNP | JUNIPER PHARMACEUT ... | Andrews Valerie Lynne | Director | Payment of Exercise | F | 2.21 | 1,000 | 2,210 | 8,000 | 9 K to 8 K (-11.11 %) |
May 17 2007 | JNP | JUNIPER PHARMACEUT ... | KASNET STEPHEN G | Director | Grant | A | 0.01 | 10,965 | 110 | 56,965 | 46 K to 57 K (+23.84 %) |
May 17 2007 | JNP | JUNIPER PHARMACEUT ... | MILLS ROBERT S | Chief Executive Off ... | Payment of Exercise | F | 2.21 | 1,000 | 2,210 | 69,000 | 70 K to 69 K (-1.43 %) |
Mar 02 2007 | JNP | JUNIPER PHARMACEUT ... | MCGRANE MICHAEL | Sr. Vice President ... | Option Exercise | A | 1.42 | 240,000 | 340,800 | 240,000 | |
Mar 02 2007 | JNP | JUNIPER PHARMACEUT ... | MCGRANE MICHAEL | Sr. Vice President ... | Grant | A | 0.01 | 16,000 | 160 | 66,875 | 50.9 K to 66.9 K (+31.45 %) |
Mar 02 2007 | JNP | JUNIPER PHARMACEUT ... | Meer James | Sr. Vice President ... | Option Exercise | A | 1.42 | 210,000 | 298,200 | 210,000 | |
Mar 02 2007 | JNP | JUNIPER PHARMACEUT ... | Meer James | Sr. Vice President ... | Grant | A | 0.01 | 14,000 | 140 | 24,000 | 10 K to 24 K (+140.00 %) |
Mar 02 2007 | JNP | JUNIPER PHARMACEUT ... | MILLS ROBERT S | Chief Executive Off ... | Option Exercise | A | 1.42 | 300,000 | 426,000 | 300,000 | |
Mar 02 2007 | JNP | JUNIPER PHARMACEUT ... | MILLS ROBERT S | Chief Executive Off ... | Grant | A | 0.01 | 20,000 | 200 | 70,000 | 50 K to 70 K (+40.00 %) |
Feb 21 2007 | JNP | JUNIPER PHARMACEUT ... | CURRAN JOHN P | 10% Owner | Sell | S | 1.41 | 178,991 | 251,518 | 4,870,620 | 5 M to 4.9 M (-3.54 %) |
Feb 21 2007 | JNP | JUNIPER PHARMACEUT ... | CURRAN JOHN P | 10% Owner | Sell | S | 1.40 | 144,509 | 202,168 | 5,049,611 | 5.2 M to 5 M (-2.78 %) |
Feb 07 2007 | JNP | JUNIPER PHARMACEUT ... | KNOTT DAVID M | 10% Owner | Sell | S | 1.42 | 76,600 | 109,109 | 140,000 | 216.6 K to 140 K (-35.36 %) |
Feb 07 2007 | JNP | JUNIPER PHARMACEUT ... | KNOTT DAVID M | 10% Owner | Sell | S | 1.42 | 664,000 | 945,802 | 1,090,270 | 1.8 M to 1.1 M (-37.85 %) |
Feb 07 2007 | JNP | JUNIPER PHARMACEUT ... | KNOTT DAVID M | 10% Owner | Sell | S | 1.42 | 234,100 | 333,452 | 513,100 | 747.2 K to 513.1 K (-31.33 %) |
Feb 07 2007 | JNP | JUNIPER PHARMACEUT ... | KNOTT DAVID M | 10% Owner | Sell | S | 1.42 | 425,300 | 605,797 | 570,480 | 995.8 K to 570.5 K (-42.71 %) |
Jan 10 2007 | JNP | JUNIPER PHARMACEUT ... | KNOTT DAVID M | 10% Owner | Option Exercise | P | 5.50 | 12,172 | 66,946 | 12,172 | |
Jan 10 2007 | JNP | JUNIPER PHARMACEUT ... | KNOTT DAVID M | 10% Owner | Option Exercise | P | 5.50 | 4,743 | 26,087 | 4,743 | |
Jan 10 2007 | JNP | JUNIPER PHARMACEUT ... | KNOTT DAVID M | 10% Owner | Option Exercise | P | 5.50 | 225,143 | 1,238,287 | 225,143 |